These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 34215409)

  • 1. New Designer Drugs.
    Levine M; Lovecchio F
    Emerg Med Clin North Am; 2021 Aug; 39(3):677-687. PubMed ID: 34215409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can Naloxone Be Used to Treat Synthetic Cannabinoid Overdose?
    Jones JD; Nolan ML; Daver R; Comer SD; Paone D
    Biol Psychiatry; 2017 Apr; 81(7):e51-e52. PubMed ID: 27765269
    [No Abstract]   [Full Text] [Related]  

  • 3. Amount of naloxone used to reverse opioid overdoses outside of medical practice in a city with increasing illicitly manufactured fentanyl in illicit drug supply.
    Bell A; Bennett AS; Jones TS; Doe-Simkins M; Williams LD
    Subst Abus; 2019; 40(1):52-55. PubMed ID: 29558283
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of opioid overdose: current approaches and recent advances.
    Britch SC; Walsh SL
    Psychopharmacology (Berl); 2022 Jul; 239(7):2063-2081. PubMed ID: 35385972
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Drugs of Abuse.
    Akerele E; Olupona T
    Psychiatr Clin North Am; 2017 Sep; 40(3):501-517. PubMed ID: 28800805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in drug use behaviors coinciding with the emergence of illicit fentanyl among people who use drugs in Vancouver, Canada.
    Brar R; Grant C; DeBeck K; Milloy MJ; Fairbairn N; Wood E; Kerr T; Hayashi K
    Am J Drug Alcohol Abuse; 2020 Sep; 46(5):625-631. PubMed ID: 32689810
    [No Abstract]   [Full Text] [Related]  

  • 7. Non-Medical Use of Novel Synthetic Opioids: A New Challenge to Public Health.
    Lovrecic B; Lovrecic M; Gabrovec B; Carli M; Pacini M; Maremmani AGI; Maremmani I
    Int J Environ Res Public Health; 2019 Jan; 16(2):. PubMed ID: 30634521
    [No Abstract]   [Full Text] [Related]  

  • 8. Naloxone Dosing After Opioid Overdose in the Era of Illicitly Manufactured Fentanyl.
    Carpenter J; Murray BP; Atti S; Moran TP; Yancey A; Morgan B
    J Med Toxicol; 2020 Jan; 16(1):41-48. PubMed ID: 31471760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Naloxone for heroin, prescription opioid, and illicitly made fentanyl overdoses: Challenges and innovations responding to a dynamic epidemic.
    Fairbairn N; Coffin PO; Walley AY
    Int J Drug Policy; 2017 Aug; 46():172-179. PubMed ID: 28687187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combative Treatment for Carfentanil Epidemic.
    Konapur R; Searls N; Babcock CCK; Blough E; Patel I
    J Addict Nurs; 2019; 30(1):2-3. PubMed ID: 30829994
    [No Abstract]   [Full Text] [Related]  

  • 11. Loperamide Addiction: Atypical Opioid Use Disorder Treated With Buprenorphine/Naloxone.
    Varghese SP; Kumari P; Wijegunaratne H; Yovankin T; Garlapati V; Koola MM
    Prim Care Companion CNS Disord; 2019 Jul; 21(4):. PubMed ID: 31274259
    [No Abstract]   [Full Text] [Related]  

  • 12. The rising crisis of illicit fentanyl use, overdose, and potential therapeutic strategies.
    Han Y; Yan W; Zheng Y; Khan MZ; Yuan K; Lu L
    Transl Psychiatry; 2019 Nov; 9(1):282. PubMed ID: 31712552
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infant and Toddler Ingestion of Illicit Fentanyl: A Case Series.
    Slingsby B; Moore JL; Barron CE
    Clin Pediatr (Phila); 2019 Nov; 58(13):1449-1451. PubMed ID: 31544503
    [No Abstract]   [Full Text] [Related]  

  • 14. Distribution of take-home opioid antagonist kits during a synthetic opioid epidemic in British Columbia, Canada: a modelling study.
    Irvine MA; Buxton JA; Otterstatter M; Balshaw R; Gustafson R; Tyndall M; Kendall P; Kerr T; Gilbert M; Coombs D
    Lancet Public Health; 2018 May; 3(5):e218-e225. PubMed ID: 29678561
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Opioid-induced respiratory effects: new data on buprenorphine.
    Dahan A
    Palliat Med; 2006; 20 Suppl 1():s3-8. PubMed ID: 16764215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Higher doses of naloxone are needed in the synthetic opiod era.
    Moss RB; Carlo DJ
    Subst Abuse Treat Prev Policy; 2019 Feb; 14(1):6. PubMed ID: 30777088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a novel opioid,
    Calello DP; Aldy K; Jefri M; Nguyen TT; Krotulski A; Logan B; Brent J; Wax P; Walton S; Manini AF;
    Clin Toxicol (Phila); 2022 Sep; 60(9):1067-1069. PubMed ID: 35708103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controversies and carfentanil: We have much to learn about the present state of opioid poisoning.
    Cole JB; Nelson LS
    Am J Emerg Med; 2017 Nov; 35(11):1743-1745. PubMed ID: 28851500
    [No Abstract]   [Full Text] [Related]  

  • 19. Abuse of fentanyl: An emerging problem to face.
    Kuczyńska K; Grzonkowski P; Kacprzak Ł; Zawilska JB
    Forensic Sci Int; 2018 Aug; 289():207-214. PubMed ID: 29902699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Contribution of Prescribed and Illicit Opioids to Fatal Overdoses in Massachusetts, 2013-2015.
    Walley AY; Bernson D; Larochelle MR; Green TC; Young L; Land T
    Public Health Rep; 2019; 134(6):667-674. PubMed ID: 31577519
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.